Eprozinol
From Wikipedia, the free encyclopedia
Eprozinol | ||
---|---|---|
IUPAC name (RS)-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-1-ol | ||
Identifiers | ||
CAS number | 32665-36-4 | |
PubChem | 122553 | |
KEGG | D07379 | |
ATC code | R03 | |
Jmol-3D images | Image 1 | |
| ||
Properties | ||
Molecular formula | C22H30N2O2 | |
Molar mass | 354.4858 | |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | ||
Infobox references | ||
Eprozinol is a drug for obstructive airway disease.[1][2]
References
- ↑ Nicrosini, F.; Carpinella, G. (1978). "Eprozinol treatment of chronic bronchitis with dyspnea and cough". Broncho-pneumologie 28 (4): 322–327. PMID 756799.
- ↑ Labrid, C.; Duchene-Marullaz, P.; Rispat, G. (1981). "Mechanisms of anti-bronchoconstrictive effects of eprozinol. II. In vivo studies on the guinea pig". Pharmacology 23 (1): 48–55. PMID 7312935.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.